Harris E. Foster Jr, MD
Professor of UrologyCards
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileContact Info
Urology
PO Box 208058
New Haven, CT 06520-8058
United States
About
Titles
Professor of Urology
Biography
Clinical Interests: Female urology, urodynamics, neurogenic bladder, male and female urinary incontinence, interstitial cystitis; voiding dysfunction; benign prostatic hyperplasia, erectile dysfunction, urologic cancers.
Dr. Harris E. Foster Jr. is board certified in urology and has specialized interests in voiding dysfunction and female urology. Particular to this area include treatment of female and male urinary incontinence, neurogenic bladder, benign prostatic hyperplasia (BPH), interstitial cystitis, urethral diverticula and vesicovaginal fisulae. In addition, Dr. Foster treats general urological conditions such as kidney stones, erectile dysfunction, prostate cancer, superficial bladder cancer, and benign conditions involving the scrotum (hydrocele, epididymal cyst). He also performs circumcision and vasectomy in patients who desire these procedures. Dr. Foster has expertise in the evaluation of voiding dysfunction utilizing urodynamics.
Dr. Foster earned his undergraduate degree from the University of Michigan at Ann Arbor. He then graduated with honors from University of Miami School of Medicine, a member of the Alpha Omega Alpha medical honor society. Dr. Foster subsequently completed his urology residency at the University of Michigan Hospitals and joined the faculty at Yale University School of Medicine. Dr. Foster is Chief of Urology for the Veteran’s Administration Connecticut Healthcare System and is a urology consultant at the Gaylord Rehabilitation Hospital in Wallingford, Conn. and The Hospital for Special Care in New Britain, Connecticut. He also provides urological care at the Yale Health Services. Dr. Foster has received grants from the National Institutes of Health (NIH) to perform clinical trials investigating the pharmacologic and phytotherapeutic treatment of BPH. He was also the chairman for many years of the NIH sponsored Interstitial Cystitis Collaborative Research Network. Dr. Foster was a member of the American Board of Urology Examination Committee and has functioned as an oral board examiner for this organization. He has written numerous research publications and textbook chapters and is a reviewer for many of the major urology journals including The Journal of Urology, Urology, and Neurourology and Urodynamics. Finally, Dr. Foster has been a member of the guidelines committee for the evaluation and treatment of BPH and overactive bladder (OAB) sponsored by the American Urological Association.
Dr. Foster is dedicated to treating patients suffering from urological diseases with a particular focus on those who have voiding dysfunction. He recognizes that although most of these disorders do not affect duration of life, they can in many instances have significant if not devastating effects on quality of life. Despite being a urological surgeon, he fully understands that surgery is not frequently indicated nor is it always the best option for many patients.
Appointments
Urology
ProfessorPrimary
Other Departments & Organizations
- Benign Prostatic Hyperplasia Program
- Lower Urinary Tract Dysfunction (LUTD) & Genitourinary Reconstruction
- Neurogenic Bladder Program
- Neurourology/Neurogenic Bladder
- Reconstructive Urologic Surgery & Trauma Program
- Urology
- Yale Medicine
- Yale Ventures
Education & Training
- Resident
- University of Michigan, Ann Arbor, MI (1992)
- Resident
- University of Michigan, Ann Arbor, MI (1989)
- MD
- University of Miami (1987)
Research
Overview
Medical Research Interests
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Robert M. Weiss, MD, FACS, FAAP
Morton Glickman, MD
Prostate
Cystitis, Interstitial
Prostatic Hyperplasia
Nitric Oxide Synthase
Urology
Publications
2020
Reply by Authors.
Foster H, Dahm P, Kohler T, Lerner L, Parsons J, Wilt T, McVary K. Reply by Authors. Journal Of Urology 2020, 203: 1219-1221. PMID: 32068490, DOI: 10.1097/ju.0000000000000802.Peer-Reviewed Original ResearchCitations
2019
Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019.
Foster H, Dahm P, Kohler TS, Lerner LB, Parsons JK, Wilt TJ, McVary K. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019. Journal Of Urology 2019, 202: 592-598. PMID: 31059668, DOI: 10.1097/ju.0000000000000319.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsBenign prostatic hyperplasiaLUTS/benign prostatic hyperplasiaLower urinary tract symptomsUrinary tract symptomsTract symptomsSurgical managementProstatic hyperplasiaMale lower urinary tract symptomsEvidence-based surgical managementAssociated treatment algorithmFuture surgical optionsPre-operative testsInvasive surgical therapiesEvidence-based recommendationsQuality of lifeSufficient evidenceHealthcare of patientsLUTS increasesSurgical therapyConditional recommendationSurgical optionsTreatment algorithmCochrane LibraryBody of evidenceImportant diagnosis
2012
2199 RENAL TRACT ULTRASONOGRAPHY FOR ROUTINE SURVEILLANCE IN SPINAL CORD INJURY PATIENTS
Edokpolo L, Foster H. 2199 RENAL TRACT ULTRASONOGRAPHY FOR ROUTINE SURVEILLANCE IN SPINAL CORD INJURY PATIENTS. Journal Of Urology 2012, 187: e886-e887. DOI: 10.1016/j.juro.2012.02.2373.Peer-Reviewed Original Research1744 IMPROVEMENTS IN LOWER URINARY TRACT SYMPTOM SEVERITY ARE ASSOCIATED WITH IMPROVEMENTS IN SLEEP DISTURBANCE OVER TIME
Helfand B, Sharp V, Williams O, Foster H, Naslund M, Lee J, McVary K. 1744 IMPROVEMENTS IN LOWER URINARY TRACT SYMPTOM SEVERITY ARE ASSOCIATED WITH IMPROVEMENTS IN SLEEP DISTURBANCE OVER TIME. Journal Of Urology 2012, 187: e703-e704. DOI: 10.1016/j.juro.2012.02.1705.Peer-Reviewed Original ResearchCitations
2011
POD-04.06 The Effect of Increasing Doses of a Saw Palmetto Fruit Extract on Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Randomized Trial
Roehrborn C, McVary K, Nickel J, Crawford E, Kreder K, Naslund M, Andriole G, Kaplan S, Foster H, Kusek J. POD-04.06 The Effect of Increasing Doses of a Saw Palmetto Fruit Extract on Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Randomized Trial. Urology 2011, 78: s14. DOI: 10.1016/j.urology.2011.07.427.Peer-Reviewed Original ResearchCitations
2010
1035 RANDOMIZED MULTICENTER CLINICAL TRIAL SHOWS EFFICACY OF MYOFASCIAL PHYSICAL THERAPY IN WOMEN WITH INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME (IC/PBS)
Payne C, Fitzgerald M, Burks D, Nickel J, Lukacz E, Kreder K, Chai T, Hanno P, Mayer R, Yang C, Peters K, Foster H, Landis J, Cen L, Propert K, Kusek J. 1035 RANDOMIZED MULTICENTER CLINICAL TRIAL SHOWS EFFICACY OF MYOFASCIAL PHYSICAL THERAPY IN WOMEN WITH INTERSTITIAL CYSTITIS/PAINFUL BLADDER SYNDROME (IC/PBS). Journal Of Urology 2010, 183: e402-e403. DOI: 10.1016/j.juro.2010.02.2113.Peer-Reviewed Original ResearchCitations
2006
Age‐related changes in the properties of α1‐adrenoceptors in the rat genitourinary tract
Yono M, Foster H, Yoshida M, Ueda S, Weiss R, Latifpour J. Age‐related changes in the properties of α1‐adrenoceptors in the rat genitourinary tract. The FASEB Journal 2006, 20: a254-a254. DOI: 10.1096/fasebj.20.4.a254-a.Peer-Reviewed Original ResearchConceptsLower urinary tract symptomsRat genitourinary tractBenign prostatic hyperplasiaΑ1-AR antagonistsAge-related changesMonth old ratsGenitourinary tractOld ratsBladder baseBladder domeDorsolateral prostateVentral prostateUrinary tract symptomsMaximum contractile responseLow testosterone levelsRadioligand receptor bindingSignificant age-dependent differencesReal-time RT-PCR techniqueAge-dependent differencesHigher body weightRT-PCR techniqueTract symptomsContractile responseOlder patientsSubtype mRNAs
2005
1443: Molecular Classification of Doxazosin-Induced Alterations in Rat Prostate by Gene Expression Profiling
Yono M, Foster H, Shin D, Takahashi W, Latifpour J. 1443: Molecular Classification of Doxazosin-Induced Alterations in Rat Prostate by Gene Expression Profiling. Journal Of Urology 2005, 173: 391. DOI: 10.1016/s0022-5347(18)35577-0.Peer-Reviewed Original Research1639: Development of a Nomogram to Predict Symptom Progression with or without Medical Therapy in Men with BPH Based on Data from the MTOPS Trial
Slawin K, Roehrborn C, McConnell J, Kreder K, Jacobs S, McVary K, Foster H, Clarke H, Milam D, Noble W, Nyberg L, Kusek J, Kattan M. 1639: Development of a Nomogram to Predict Symptom Progression with or without Medical Therapy in Men with BPH Based on Data from the MTOPS Trial. Journal Of Urology 2005, 173: 444. DOI: 10.1016/s0022-5347(18)35761-6.Peer-Reviewed Original ResearchCitations1440: Chronic Doxazosin Treatment Differentially Alters Gene Expression of α1-Adrenoceptor Subtypes in Rat Tissues
Foster H, Yono M, Shin D, Takahashi W, Latifpour J. 1440: Chronic Doxazosin Treatment Differentially Alters Gene Expression of α1-Adrenoceptor Subtypes in Rat Tissues. Journal Of Urology 2005, 173: 390. DOI: 10.1016/s0022-5347(18)35574-5.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
activity Peer Review committee - SCORS, National Institutes of Health
Professional OrganizationsReviewerDetailsactivity GMEC (Graduate Medical Education Committee)
CommitteesMemberDetailsactivity American Urological Association Benign Prostatic Hyperplasia (BPH) Guidelines Committee
Professional OrganizationsMemberDetails2007 - 2015activity Societe Internationale D'Urologie
Professional OrganizationsMemberDetails1999 - 2015activity Sigma Xi Scientific Research Society
Professional OrganizationsMemberDetails1997 - 2015
Clinical Care
Overview
Harris E. Foster, Jr., MD, an expert in caring for patients with urological diseases, treats general urological conditions and has deep knowledge of voiding dysfunction, which occurs when the bladder muscle and urethra have poor coordination. He also sees patients with neurogenic bladder, which can develop with a brain, spinal cord or nerve condition.
Dr. Foster says that while many urological conditions do not affect duration of life, they can in many instances have significant, if not devastating, effects on quality of life. He works with each patient to come up with the best treatment, which he says may not always be surgery.
A professor of urology at the Yale School of Medicine, Dr. Foster focuses his clinical research on pharmacologic and phytotherapeutic treatments of benign prostate hyperplasia, also known as enlarged prostate. He has also served as director of a national interstitial cystitis research network. Connecticut Magazine has included Dr. Harris in its annual list of the Top Doctors in the state.
Clinical Specialties
Fact Sheets
Neurogenic Bladder and Incontinence
Learn More on Yale MedicinePediatric Neurogenic Bladder
Learn More on Yale MedicineEnlarged Prostate (Benign Prostatic Hyperplasia)
Learn More on Yale MedicineUroLift
Learn More on Yale Medicine
Yale Medicine News
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileNews & Links
News
- November 19, 2024
2nd Annual Yale Urology Bulldog Debates Recap
- November 04, 2024
Yale Urology’s First Female Professor
- January 19, 2024
Yale Urology Research [Q4: October-December 2023]
- October 04, 2023
Bulldog Debates Recap
Related Links
Get In Touch
Contacts
Urology
PO Box 208058
New Haven, CT 06520-8058
United States
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.